Pure cannabidiol in the treatment of malignant migrating partial seizures in infancy: a case report.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Pediatric Neurology

• Publication date

  2015-05-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/j.pediatrneurol.2015.02.008PMID 25882081
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Malignant migrating partial seizures of infancy

  2020cited by this paper
• Therapeutic potential of cannabinoid medicines.

  2014cited by this paper
• Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders

  2014cited by this paper
• The case for medical marijuana in epilepsy

  2014cited by this paper
• Cannabinoids for epilepsy.

  2014cited by this paper
• Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy.

  2013cited by this paper
• Malignant migrating partial seizures in infancy.

  2013cited by this paper
• De novo SCN1A mutations in migrating partial seizures of infancy

  2011cited by this paper
• The efficacy of bromides, stiripentol and levetiracetam in two patients with malignant migrating partial seizures in infancy

  2011cited by this paper
• Treatment of malignant migrating partial epilepsy of infancy with rufinamide: report of five cases

  2011cited by this paper
• Novel SCN1A mutation in a proband with malignant migrating partial seizures of infancy.

  2011cited by this paper
• Rufinamide for Pediatric Patients with Lennox-Gastaut Syndrome

  2011cited by this paper
• Malignant migrating partial seizures in infancy: An epilepsy syndrome of unknown etiology

  2009cited by this paper
• Migrating Focal Seizures in Infancy: Analysis of the Electroclinical Patterns in 17 Patients

  2008cited by this paper
• When do seizures usually improve with the ketogenic diet?

  2008cited by this paper
• Migrating Partial Seizures in Infancy: Expanding the Phenotype of a Rare Seizure Syndrome

  2005cited by this paper
• [Ketogenic regime as anti-epileptic treatment: its use in 29 epileptic children].

  2003cited by this paper
• Le régime cétogène à visée anti-épileptique : son utilisation chez 29 enfants épileptiques

  2003cited by this paper
• Migrating Partial Seizures in Infancy: A Malignant Disorder with Developmental Arrest

  1995cited by this paper

• A systematic review of highly purified cannabidiol in developmental and epileptic encephalopathies and complex treatment-resistant epilepsies: Changes in seizure frequency and adverse events.

  2026cites this paper
• Long‐term efficacy and safety of cannabidiol in patients with treatment‐resistant focal epilepsies treated in the Expanded Access Program

  2025cites this paper
• Management of Developmental and Epileptic Encephalopathies

  2025cites this paper
• Medicinal Cannabinoids in Children: A Scoping Review

  2025cites this paper
• A Systemic Review of Medical Cannabinoids Dosing in Human.

  2022cites this paper
• Approaches for the discovery of drugs that target K Na 1.1 channels in KCNT1-associated epilepsy

  2022cites this paper
• Cannabidiol for the treatment of refractory epilepsy in children: a critical review of the literature

  2022cites this paper
• Uncommon epileptic syndromes in children: a review.

  2021cites this paper
• Channelopathy of Dravet Syndrome and Potential Neuroprotective Effects of Cannabidiol

  2021cites this paper
• Treatments with cannabinoids and brain development

  2021cites this paper
• Highly Purified Cannabidiol for Epilepsy Treatment: A Systematic Review of Epileptic Conditions Beyond Dravet Syndrome and Lennox–Gastaut Syndrome

  2021influential citation
• Pharmacotherapy for Medication-Resistant Epilepsy

  2020cites this paper
• Cannabis Use for Therapeutic Purposes by Children and Youth at a Tertiary Teaching Hospital in Canada: A Retrospective Chart Review.

  2020cites this paper
• Effectiveness of cannabidiol in a prospective cohort of children with drug-resistant epileptic encephalopathy in Argentina.

  2020cites this paper
• Cannabidiol Treatment for Refractory Epilepsies in Pediatrics

  2020cites this paper
• Mortality and Morbidity of Medication-Resistant Epilepsy

  2020cites this paper
• The Economic Impact of Medication-Resistant Epilepsy

  2020cites this paper
• Autoimmune Causes of Medication-Resistant Epilepsy

  2020cites this paper
• Hippocampal Sclerosis as a Cause of Medication-Resistant Epilepsy

  2020cites this paper
• Medication-Resistant Epilepsy Syndromes in Children

  2020cites this paper
• International League Against Epilepsy’s Definition of Medication-Resistant Epilepsy

  2020cites this paper
• Reproductive Health for Women with Medication-Resistant Epilepsy

  2020cites this paper
• Diet Therapy for Medication-Resistant Epilepsy

  2020cites this paper
• Genetic Causes of Medication-Resistant Epilepsy

  2020cites this paper
• Ablative Surgery for Medication-Resistant Epilepsy

  2020cites this paper
• Neurobiology of Medication-Resistant Epilepsy

  2020cites this paper
• Medication-Resistant Epilepsy in Adults

  2020cites this paper
• The Natural History of Epilepsy

  2020cites this paper
• Botanical Treatments for Medication-Resistant Epilepsy

  2020cites this paper
• Challenges in Identifying Medication-Resistant Epilepsy

  2020cites this paper
• Approach to the Treatment of Medication-Resistant Epilepsy

  2020cites this paper
• Social Consequences of Medication-Resistant Epilepsy

  2020cites this paper
• Malformations of Cortical Development as Causes of Medication-Resistant Epilepsy

  2020cites this paper
• Resective Surgery for Medication-Resistant Epilepsy

  2020cites this paper
• Psychiatric Comorbidities in Medication-Resistant Epilepsy

  2020cites this paper
• Models for Medication-Resistant Epilepsy

  2020cites this paper
• Stimulation Treatment for Medication-Resistant Epilepsy

  2020cites this paper
• Index

  2020cites this paper
• Medication-Resistant Epilepsy

  2020cites this paper
• Pharmacological and Therapeutic Properties of Cannabidiol for Epilepsy

  2019cites this paper
• A systematic review of cannabidiol dosing in clinical populations

  2019cites this paper
• Response to cannabidiol in epilepsy of infancy with migrating focal seizures associated with KCNT1 mutations: An open-label, prospective, interventional study.

  2019cites this paper
• Neuroprotective Effects of Low Dose Anandamide in Pentylenetetrazole-Induced Kindling in Rats

  2019cites this paper
• The level of evidence of medical marijuana use for treating disabilities: a scoping review

  2018cites this paper
• Neural Tube Development

  2018cites this paper
• Prospects of Cannabidiol for Easing Status Epilepticus-Induced Epileptogenesis and Related Comorbidities

  2018cites this paper
• Cannabis for paediatric epilepsy: challenges and conundrums

  2018cites this paper
• Cannabinoid signalling in the immature brain: Encephalopathies and neurodevelopmental disorders

  2018cites this paper
• Medical cannabis: A needs analysis for people with epilepsy.

  2018cites this paper
• Evidence for cannabis and cannabinoids for epilepsy: a systematic review of controlled and observational evidence

  2018cites this paper
• Prospects of Cannabidiol for Easing Status Epilepticus-Induced Epileptogenesis and Related Comorbidities

  2018cites this paper
• Medical Cannabinoids in Children and Adolescents: A Systematic Review

  2017cites this paper
• Anticonvulsant effect of cannabidiol in the pentylenetetrazole model: Pharmacological mechanisms, electroencephalographic profile, and brain cytokine levels.

  2017cites this paper
• Cannabinoids in the Treatment of Epilepsy: Hard Evidence at Last?

  2017cites this paper
• [Epileptic encephalopathies in infancy. How do we treat them? Does the aetiology influence the response to treatment?]

  2017cites this paper
• Cognitive and Social Outcomes of Epileptic Encephalopathies.

  2017cites this paper
• Cannabinoids: A Group of Promising Neuroprotective Agents

  2017cites this paper
• Neurological Aspects of Medical Use of Cannabidiol.

  2017cites this paper
• The current state and potential direction of cannabis research

  2016cites this paper
• Cannabidiol and epilepsy: Rationale and therapeutic potential.

  2016cites this paper
• Cannabidiol as potential treatment in refractory pediatric epilepsy

  2016cites this paper
• From Cannabis to Cannabidiol to Treat Epilepsy, Where Are We?

  2016cites this paper
• Weeding Out the Truth: Adolescents and Cannabis

  2016cites this paper
• Clearing the Smoke on Cannabis Medical Use of Cannabis and Cannabinoids – An Update

  2016cites this paper
• Cannabis and Endocannabinoid Signaling in Epilepsy.

  2015cites this paper
• Marijuana Use in Epilepsy: The Myth and the Reality

  2015cites this paper